NI Jian - Net Worth and Insider Trading

NI Jian Net Worth

The estimated net worth of NI Jian is at least $201 Million dollars as of 2025-04-09. NI Jian is the of Biocytogen Pharmaceuticals (Beijing) Co Ltd and owns about 16,854,300 shares of Biocytogen Pharmaceuticals (Beijing) Co Ltd (HKSE:02315) stock worth over $201 Million. Details can be seen in NI Jian's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that NI Jian has not made any transactions after 2022-09-01 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of NI Jian

NI Jian Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, NI Jian owns 1 companies in total, including Biocytogen Pharmaceuticals (Beijing) Co Ltd (HKSE:02315) .

Click here to see the complete history of NI Jian’s form 4 insider trades.

Insider Ownership Summary of NI Jian

Ticker	Comapny	Transaction Date	Type of Owner
HKSE:02315	Biocytogen Pharmaceuticals (Beijing) Co Ltd	2022-09-01

NI Jian Latest Holdings Summary

NI Jian currently owns a total of 1 stock. NI Jian owns 16,854,300 shares of Biocytogen Pharmaceuticals (Beijing) Co Ltd (HKSE:02315) as of September 1, 2022, with a value of $201 Million.

Latest Holdings of NI Jian

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
HKSE:02315	Biocytogen Pharmaceuticals (Beijing) Co Ltd	2022-09-01	16,854,300	11.90	200,566,170

Holding Weightings of NI Jian

NI Jian Form 4 Trading Tracker

According to the SEC Form 4 filings, NI Jian has made a total of 1 transactions in Biocytogen Pharmaceuticals (Beijing) Co Ltd (HKSE:02315) over the past 5 years, including 0 buys and 0 sells. The most-recent trade in Biocytogen Pharmaceuticals (Beijing) Co Ltd is the sale of 0 shares on September 1, 2022, which brought NI Jian around $0.

Insider Trading History of NI Jian

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

NI Jian Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

NI Jian Ownership Network

Ownership Network List of NI Jian

No Data

Ownership Network Relation of NI Jian

NI Jian Owned Company Details

What does Biocytogen Pharmaceuticals (Beijing) Co Ltd do?

Who are the key executives at Biocytogen Pharmaceuticals (Beijing) Co Ltd?

NI Jian is the of Biocytogen Pharmaceuticals (Beijing) Co Ltd. Other key executives at Biocytogen Pharmaceuticals (Beijing) Co Ltd include 2101 Beneficial owner wei ke xiang gang jing mao you xian gong si , 2201 Interest of corporation controlled by you InnoVeda Medtech, Ltd. , and 2201 Interest of corporation controlled by you zhao yin guo ji jin rong you xian gong si .

Biocytogen Pharmaceuticals (Beijing) Co Ltd (HKSE:02315) Insider Trades Summary

Over the past 18 months, NI Jian made no insider transaction in Biocytogen Pharmaceuticals (Beijing) Co Ltd (HKSE:02315). Other recent insider transactions involving Biocytogen Pharmaceuticals (Beijing) Co Ltd (HKSE:02315) include a net purchase of 1,000,000 shares made by wei ke xiang gang jing mao you xian gong si ,

In summary, during the past 3 months, insiders sold 0 shares of Biocytogen Pharmaceuticals (Beijing) Co Ltd (HKSE:02315) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Biocytogen Pharmaceuticals (Beijing) Co Ltd (HKSE:02315) were sold and 1,000,000 shares were bought by its insiders, resulting in a net purchase of 1,000,000 shares.

Biocytogen Pharmaceuticals (Beijing) Co Ltd (HKSE:02315)'s detailed insider trading history can be found in Insider Trading Tracker table.

Biocytogen Pharmaceuticals (Beijing) Co Ltd Insider Transactions

No Available Data

NI Jian Mailing Address

Above is the net worth, insider trading, and ownership report for NI Jian. Currently GuruFocus does not have mailing address information for NI Jian.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.